To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. When prompted, use PIN number 19695460. Dial in approximately ten minutes prior to the scheduled teleconference time. A rebroadcast of the call will be available starting approximately two hours after the conference call ends, through midnight (E.T.) Wednesday, March 27, 2013. The replay of the conference call can be accessed by dialing 1-800-585-8367 (International callers can dial 1-404-537-3406) and, when prompted, use the same PIN number 19695460.
Enzo’s conference call can also be accessed live over the Internet at http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=94391&eventID=4925179
To listen to the live call, individuals should go to the web site at least 15 minutes early to register, download and install any necessary audio software. Any pop up blocker installed on your PC should be disabled while accessing the webcast.
A press release announcing second quarter results will be distributed Tuesday, March 12, 2013 after the market close.
Enzo Biochem is engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques, and in providing diagnostic services to the medical community.
Except for historical information, the matters discussed in this news release may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses are dependent on a number of factors outside of the control of the company including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. See Risk Factors in the Company’s Form 10-K for the fiscal year ended July 31, 2010. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this press release.
For: Enzo Biochem, Inc.
Steve Anreder, 212-532-3232
Michael Wachs, CEOcast, Inc., 212-732-4300
|Dynatronics To Release Fiscal Second Quarter Results Wednesday, February 13, 2013; Conference Call set for 3:00 p.m. ET (2013/2/12)|
|UniFirst Corporation Plans to Announce Second Quarter Results on March 27, 2013 (2013/2/21)|
|Smith Micro Software Schedules Teleconference to Discuss Fourth Quarter and Full-Year 2012 Financial Results (2013/1/30)|
|REMINDER: BofI Holding Inc. Announces Conference Call to Discuss Second Quarter Results (2013/2/4)|
|Smith Micro Software Schedules Teleconference to Discuss First Quarter 2013 Financial Results (2013/4/17)|
|Global Sources scheduled to report fourth quarter and year-end 2012 results on March 13, 2013 (2013/2/27)|
|CPHI to Hold Fiscal Year 2012 Earnings Conference Call on Friday, March 15, 2013 at 8:30 a.m. ET (2013/3/5)|
|Frequency Electronics Announces Earnings Conference Call; Wednesday, March 13, 2013, at 2:30 PM ET (2013/3/12)|
|Webcast Alert: Finish Line Fourth Quarter Fiscal Year 2013 Webcast March 28, 2013 at 8:30 a.m. Eastern (2013/3/11)|
|Perion Network to Announce Fourth Quarter and Year End 2012 Financial Results on March 13, 2013 (2013/2/21)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.